Precision Medicine Redefines Evolving Thyroid Cancer Care
*Corresponding Author: Anika Suleiman, Turkey National Medical Research Centre, Turkey, Email: anika.suleiman@turkeyhealth.trReceived Date: Sep 01, 2025 / Accepted Date: Sep 29, 2025 / Published Date: Sep 29, 2025
Citation: Suleiman A (2025) Precision Medicine Redefines Evolving Thyroid Cancer Care. jcd 09: 320.DOI: 10.4172/2476-2253.1000320
Copyright: © 2025 Anika Suleiman This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
This collection outlines recent advancements in thyroid cancer management, emphasizing personalized approaches, novel thera
pies like targeted drugs and immunotherapies, and refined diagnostic techniques. It explores molecular mechanisms driving disease
progression, updates on differentiated and anaplastic thyroid cancers, and specific considerations for pediatric cases. Furthermore, it
details improvements in thyroid nodule risk stratification, aiming to optimize treatment efficacy, enhance patient quality of life, and
minimize unnecessary interventions across various manifestations of the disease.
